Beckman Coulter Life Sciences in partnership with Rarity Bioscience AB offers a new approach to oncology research by extending the capabilities of flow cytometry to clinical molecular research.
Centauri Therapeutics (Centauri), an immunotherapy company with a proprietary platform technology applicable across a wide range of therapeutic indications, has announced the selection of its first clinical candidate in the ABX-01 programme.
New research has revealed up to 70,000 additional jobs will be needed in the UK life sciences sector over the coming decade, if recent growth trends continue.
Global contract manufacturing organisation (CMO) Symbiosis Pharmaceutical Services has completed its latest inspection by the US Food and Drug Administration (FDA) of its facilities in Scotland.
Novo Holdings and TA Associates, has announced that the parties have entered into an agreement for Novo Holdings to make an investment in Biocomposites.
Full results from the positive Phase III WAYPOINT trial showed AstraZeneca and Amgen's Tezspire (tezepelumab) significantly reduced nasal polyp severity.
KAX Group has announced the launch of VEKTOR VAULT. VEKTOR VAULT records and secures data and models at every step in the process within PATForm, a total package of multivariate data analysis software.
Janssen-Cilag International NV has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended the approval of an indication extension of DARZALEX.
Honeywell has announced that it has developed a new technology, Digital Holographic Microscopy, that uses artificial intelligence (AI) to help count and classify tiny particles or cells.
